The authors have no relevant affiliations or financial interest in or financial conflict with the subject matter or materials discussed in the manuscript SUMMARY: A six-gene prognostic colorectal cancer hypoxia score was generated from expression data from in vitro experiments and microarray datasets and was validated in two distinct patient cohorts. The approach followed by the authors is original and biologically sound but could be limited by potential biases and other methodological limitations. on December 31, 2017.
analytical methods. These approaches involve an initial training step in pre-defined groups of patients, for instance, relapse versus non-relapse, to identify gene expression signatures with predictive capability. A large number of prognostic gene profiles have been discovered and developed effectively in the clinical setting 4 , but only two of them belong to commercial platforms that have succeeded in validating their signature in clinically relevant, multivariate, independent analyses 5, 6 .
Dekervel et definition. Amongst the four-gene expression omnibus (GEO) series used for the training in this paper, one has scarce clinical information and even lacks a recurrence outcome report (GSE13294 , Table 1 ). Nevertheless, this is the only one of the 4 datasets used that has information on MSI status, which was arguably used as a surrogate variable for clinical outcome. MSI status is unknown in the remaining 3 series, which makes the author´s assumptions underlying use of MSI as a surrogate parameter for clinical outcome even more unorthodox. In addition, the majority of the published prognostic signatures have reportedly performed well in two of the four datasets used in the training of the CCHS (GSE17537 and GSE5206), but not in the other public datasets, which casts doubt on the usefulness of these series for such purposes 7 . As a corollary, an obvious risk of this in sillico training approach is data set selection bias, which is a critical point in any genomic high-throughput analysis design and subsequent data interpretation. In addition, the inclusion of the p53 expression in the signature training process is based only on literature and not data, which is a questionable decision as the real role of p53 expression in prognosis of loco-regional stage CRC is not clear and not recommended in any guidelines or expert consensus publication 8 .
Regarding Importantly, CCHS was validated in these two independent groups of patients using optimal non pre-specified cut-off values (ROC curves) without internal cross-validation for each dataset. The authors justify this because of the distinct techniques used to measure the gene expression (nCounter vs. Affymetrix microarray), which is a fair argument. However, this downgrades their study to a previous step in the validation process (see Figure) , closer to what is defined by Simon et al. as Finally, the rationale behind this innovative approach to signature discovery is biologically plausible because hypoxia can be one of the drivers of epithelial mesenchymal transition (EMT) and it is well known that EMT plays an important role in cancer progression 10, 11 . In addition, recent hierarchical clustering of whole-genome expression data has provided new insights into the biologic and prognostic heterogeneity that supports this concept: subtyping studies on several groups also confirmed that upregulation of the EMT phenotype, matrix remodeling and TGF-Beta pathway is clearly associated with increased risk of relapse and/or reduced overall survival. Poor prognosis has also been observed in stem-like subtypes with overexpressed genes associated with mesenchymal and stem cells. By contrast, subtypes associated with an epithelial phenotype showed a better prognosis 12 . In conclusion, this manuscript by Dekervel et al, reports on a new candidate prognostic score based on a hypoxia induced phenotype and a novel methodological approach that requires validation. Despite the originality of the approach, a number of limitations are apparent that need to be addressed in future studies. 
